Candel Therapeutics Adds Martine Zimmermann to Board Ahead of Planned BLA Filing

Candel Therapeutics, Inc. (Nasdaq: CADL) has appointed pharmaceutical regulatory executive Martine Zimmermann, PharmD, to its board of directors as the... Read More

The post Candel Therapeutics Adds Martine Zimmermann to Board Ahead of Planned BLA Filing appeared first on citybiz.